Overview
Wei Wen practices practicing medicine in Puerto Rico.
Their clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Henoch-Schonlein Purpura, and Non-Small Cell Lung Cancer (NSCLC).
They are actively involved in clinical research, co-authoring 130 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wei Wen
Is Wei Wen a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Wei Wen is classified as an Experienced expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wei Wen participate in research or clinical trials?
Yes. Wei Wen has published 130 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Wei Wen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerWen isExperienced. Learn about EGFR Positive Lung Cancer.
- Henoch-Schonlein PurpuraWen isExperienced. Learn about Henoch-Schonlein Purpura.
- Lung CancerWen isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)